Clinical Trial Update: Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized Phase 2/3 trial is evaluating submucosal gemcitabine injections to prevent recurrence in patients with intermediate- and high-risk non-muscle-invas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Non Muscle Invasive Bladder Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING